Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Lactone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN109251207B discloses a novel method for synthesizing chiral lactones with high yield and recyclable auxiliaries, offering significant cost reduction in API manufacturing.
Patent CN101250171A details a chiral phosphine-catalyzed method for gamma-butyrolactones, offering high ee values and yield for pharmaceutical intermediate manufacturing.
Discover a novel palladium-catalyzed asymmetric allylic cycloaddition method for synthesizing chiral oxygen-containing eight-membered rings with high yield and enantioselectivity.
Advanced synthesis of optically pure 2-methyl alkyl glycol derivatives from lactones. Reliable supplier for pharma intermediates offering cost-effective, scalable chiral building blocks.
Patent CN108976123B details a Pd-catalyzed method for axial chiral allenes with 90-96% ee. Enables cost-effective synthesis of pharmaceutical intermediates and natural products like traumatic lactone.
Patent CN100548965C details scalable synthesis of optically pure omega-hydroxy acid derivatives from steroidal sapogenin waste, offering cost-effective chiral building blocks.
Patent CN101535467B discloses a novel biocatalytic route for chiral hydroxy acids using Fusarium proliferatum ECU2002, offering high optical purity and scalable manufacturing solutions.
Patent CN103003257B details a one-step L-carnitine synthesis. Offers high purity, cost reduction, and supply chain reliability for pharmaceutical intermediates.
Patent CN1495164A details a Rh-catalyzed route to chiral lactones. Offers high ee and scalable process for MMP inhibitor intermediates.
Patent CN102584800A details an asymmetric synthesis of chiral indolinone-angelica lactone frameworks using cinchona alkaloid catalysis, offering high enantioselectivity for pharmaceutical intermediates.
Patent CN1160350C details a rhodium-catalyzed route for high-purity chiral lactones, offering significant cost reduction in API manufacturing and reliable supply chain continuity.
Patent CN115073399A reveals a low-cost bifunctional catalyst for high-yield chiral beta-butyrolactone production, offering significant supply chain advantages.
Patent CN109553595A reveals mild chiral gamma-butyrolactone synthesis. Reduces cost and improves supply chain reliability for pharmaceutical intermediates.
Patent CN118359593A reveals a Ru/Cu bimetallic method for stereodivergent delta-lactone synthesis, offering high purity and cost-effective manufacturing for pharmaceutical intermediates.
Patent CN111233795B reveals organic catalytic method. High yield and stereoselectivity ensure reliable supply chain for antitumor drug manufacturing.
Patent CN111196791B reveals a novel Rh-catalyzed route to chiral gamma-butyrolactones with high enantioselectivity, offering cost-effective API intermediate solutions.
Patent CN111233795A details a novel organocatalytic route to chiral gamma-butyrolactones with high stereoselectivity, offering cost-effective API intermediate manufacturing solutions.
Novel Ni-PyIPI catalyzed [4+2] cycloaddition method ensures high enantioselectivity and scalable production for pharmaceutical intermediates. This patent offers significant cost reduction and supply chain reliability for global buyers seeking reliable API intermediate suppliers.
Solve complex synthesis challenges with this 5-step chiral resolution method. Eliminate corrosive reagents, reduce equipment costs, and ensure 99%+ purity for your pharmaceutical intermediates.